PLx Pharma Winddown Corp PLXPQ Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Sep 29
Last close · Previous close $0.00
- Market cap
- At the Sep 29 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$0.84Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedFri, Sep 29 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Sep 28
- Volume3.00KSep 29 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume5.34KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Sep 29 close. Total return includes reinvested dividends.Price change only, without dividends.
| Period | PLXPQ |
|---|---|
| Short term | |
| 1M | PLXPQ: down 99.5% |
| 3M | PLXPQ: down 100.0% |
| YTD | PLXPQ: down 100.0% |
| 1Y | PLXPQ: down 100.0% |
| Long term | |
| 3Y | PLXPQ: down 100.0% −99.3% a year |
| 5Y | PLXPQ: down 100.0% −95.2% a year |
$10,000 invested in PLXPQ 5 years ago (Sep 28, 2018) would be worth about $0 at the close on , with dividends reinvested.
| Period | PLXPQ |
|---|---|
| Short term | |
| 1M | PLXPQ: down 99.5% |
| 3M | PLXPQ: down 100.0% |
| YTD | PLXPQ: down 100.0% |
| 1Y | PLXPQ: down 100.0% |
| Long term | |
| 3Y | PLXPQ: down 100.0% −99.3% a year |
| 5Y | PLXPQ: down 100.0% −95.2% a year |
$10,000 invested in PLXPQ 5 years ago (Sep 28, 2018) would be worth about $0 at the close on , not counting dividends.
All-time high
$135.12
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Mar 13, 2014.
Stock splits
1
1-for-8 on . Share counts adjust after each split.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY22, the quarter ended Sep 30, 2022. “Last 12 months” means the four quarters from Oct 1, 2021 to Sep 30, 2022, and balance-sheet figures are as of Sep 30, 2022.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $4.54Mdown 31.3%
- Net income
- −$27.58M
- Diluted EPS
- −$0.84
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY20 (Dec 31, 2020) | −$430.00 | −$7.98M | −$0.82 |
| Q1 FY21 (Mar 31, 2021) | $0.00 | −$11.54M | −$0.73 |
| Q2 FY21 (Jun 30, 2021) | $0.00 | −$16.51M | −$0.79 |
| Q3 FY21 (Sep 30, 2021) | $6.62M | −$21.64M | −$0.80 |
| Q4 FY21 (Dec 31, 2021) | $1.59M | $3.56M | $0.28 |
| Q1 FY22 (Mar 31, 2022) | $2.08M | −$10.79M | −$0.39 |
| Q2 FY22 (Jun 30, 2022) | $483.00K | −$11.86M | −$0.43 |
| Q3 FY22 (Sep 30, 2022) | $386.00K | −$8.50M | −$0.30 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Dec 31, 2020) | $30.00K | −$15.21M | −$1.74 |
| FY21 (Dec 31, 2021) | $8.21M | −$46.13M | −$2.06 |
Margins
- Gross 4.5%
- Operating −1,417.8%
- Net −606.9%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$59.33MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$59.34MLast 12 months
- Capital spending$458.00Last 12 months
- −1,305.8%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $2.61MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $25.83MAs of Sep 30, 2022
Cash plus short- and long-term marketable securities on the Sep 30, 2022 balance sheet.
- Total debt$0.00As of Sep 30, 2022
- Net cash$25.83MAs of Sep 30, 2022
- 4.79As of Sep 30, 2022
Current assets divided by current liabilities on the Sep 30, 2022 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.00As of Sep 30, 2022
Total debt divided by shareholders’ equity on the Sep 30, 2022 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- −124.9%Last 12 months
Over the last 12 months, PLx Pharma Winddown lost money: its net loss was 124.9% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −51.2%Last 12 months
Over the last 12 months, PLx Pharma Winddown’s net loss was 51.2% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About PLx Pharma Winddown Corp
PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on improving how and where active pharmaceutical ingredients (APIs) are absorbed in the gastrointestinal (GI) tract via its clinically validated and patent protected PLxGuard™ technology. PLx believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach injury associated with certain drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- New Jersey, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
PLXPQ news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
PLXPQ stock FAQ
What is PLXPQ stock’s price today?
PLx Pharma Winddown (PLXPQ) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
If you invested $1,000 in PLXPQ 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in PLXPQ on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $0 if invested one year ago. Past performance doesn’t predict future returns.
What is PLXPQ’s P/E ratio?
PLXPQ’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$0.84).
How much revenue does PLx Pharma Winddown make?
PLx Pharma Winddown reported $4.5 million of revenue over the four quarters to , down 31.3% from the twelve months before. In its latest quarter (Q3 FY22, ended ) revenue was $386.0 thousand, down 94.2% from a year earlier.
Is PLx Pharma Winddown profitable?
Not over the four quarters to . PLx Pharma Winddown reported a net loss of $27.6 million across those four quarters on $4.5 million of revenue.
What are PLXPQ’s earnings per share?
PLXPQ’s diluted earnings per share were −$0.84 over the four quarters to , compared with −$3.14 in the twelve months before. The latest quarter (Q3 FY22) brought −$0.30 per share, against −$0.80 a year earlier (how EPS works).
Does PLXPQ pay a dividend?
PLx Pharma Winddown hasn’t paid a dividend in the last twelve months.
What is PLXPQ’s all-time high?
PLXPQ’s highest closing price was $135.12 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has PLXPQ stock ever split?
Yes, once: 1-for-8 on .
How has PLXPQ stock performed?
Including dividends and measured to the close on , PLXPQ has returned −100.0% so far this year and −100.0% over the past year, and −100.0% over five years (−95.2% a year). Past performance doesn’t predict future returns.
What sector and industry is PLx Pharma Winddown in?
PLx Pharma Winddown is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is headquartered in New Jersey, USA.
What exchange does PLXPQ trade on?
PLx Pharma Winddown trades on the PINK under the ticker symbol PLXPQ. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.